Safety Syringes Market Expected to Reach USD 6.50 Billion Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research "Safety Syringes Market Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019," the global safety syringes market was valued at USD 3.41 billion in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value of USD 6.50 billion by 2019.

Safety syringes are integrated with safety mechanisms that protect patients and healthcare professionals from accidental needlestick injuries. High risk associated with the unsafe handling of syringes that may transfer HIV, Hepatitis B, Hepatitis C and other blood borne diseases, encourages healthcare workers to adopt syringes with safety features. There are two major types of safety syringes available in the market, namely, retractable safety syringes and non-retractable safety syringes. Retractable safety syringes can be further categorized as the automatic retractable safety syringes and manual retractable safety syringes. Sheathing tube syringes equipped with sliding needle covers and hinged needle covers are the examples of non-retractable safety syringes.

Browse the full Safety Syringes Market for Implantable Devices Report athttp://www.transparencymarketresearch.com/retractable-safety-syringes.html

 Non-retractable safety syringes accounted for the larger share of the total market in 2012, both by revenue as well as volume. However, during the forecast period, retractable safety syringes are expected to experience greater demand than non-retractable safety syringes, mainly due to advantages offered by them such as improved safety, reduced time and ease of use. The market for retractable safety syringes has been anticipated to grow at a CAGR much higher than that of the syringes with protective shield during the forecast period from 2013 to 2019.

Increasing cases of needlestick injuries, governmental legislation propelling manufacturers to develop syringes with safety mechanisms and continuous growth in injectable drugs market are some major growth factors driving the market for safety syringes worldwide. A study conducted by the Centers for Disease Control and Prevention (CDC) suggests that approximately 385,000 needlestick and other sharps-related injuries occur in the U.S. each year.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2079

In order to ensure safety from accidental needlestick injuries, governments of various countries brought legislation in their respective countries mandating the use of safety syringes. The U.S. federal government signed the Needlestick Safety and Prevention Act into a law on November 6, 2000, compelling syringe and needle manufacturers to adopt product modifications in order to comply with the regulatory guidelines. Similarly, a legislation called TRBA 250 ensures the use of safety equipped syringes and needles across hospitals and physician offices in Germany. These legislations are expected to drive market growth by encouraging syringe companies to manufacture safety syringes in order to reduce injuries from needlestick and unsafe syringe usage. Similarly, the worldwide growth in the injectable drugs market will also drive the market growth for safety syringes.

Browse Pharmaceutical Market Research Reports @http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

On the other hand factors such as high product cost and availability of alternative drug delivery methods including transdermal drug delivery, nasal delivery and skin-based delivery may hamper the market growth to some extent. Geographically, North America accounted for the largest share of the overall safety syringes market in 2012 in terms of value (USD Million) as well as volume (Million Units), followed by Europe. Governmental legislation mandating the use of safety syringes across the healthcare facilities has been a key factor driving the market growth in the region. In Asia-Pacific and Rest of the World (RoW) regions, lack of strict governmental legislation regarding the use of safety syringes has been one of the major factors restraining the market growth in these regions. However, during the forecast period 2013 to 2019, growing concerns for accidental needlestick injuries will play a key role in driving the market growth in these markets. Becton Dickinson & Company, Covidien plc, Retractable, Technologies, Inc., Revolutions Medical Corporation, Smiths Medical, Terumo Corporation and Unilife Corporation are some major players operating in the safety syringes market space.

Download PDF at Safety Syringes Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019

E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

According to a new market report published by Transparency Market Research "E-Prescribing Market-Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.

Browse the full E-Prescribing Market Report at http://www.transparencymarketresearch.com/e-prescribing-market.html

The global E-Prescribing market is witnessing a significant growth led by various government programs to implement E-Prescribing systems in order to improve quality of healthcare and reduce medication errors. The E-Prescribing system is used in various applications including preparation of complete medication list, data security checks, complete information of formulary and patient historical data. These advanced features of E-Prescribing are some of the key driving factors for the E-Prescribing market. Additionally, improved healthcare infrastructure has increased the demand for E-Prescribing system. Moreover, implementation of electronic healthcare records with E-Prescribing system holds immense potential for the growth of E-Prescribing market. E-Prescribing market is expected to grow a CAGR of about 23.5% during 2013-2019.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=929

On the other hand, high cost of E-Prescribing system and lack of patient privacy and security impede the growth of E-Prescribing market. Moreover, lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.

Europe is the largest market for E-Prescribing system. Many eHealth projects in Europe are playing a vital role in the adoption of E-Prescribing system such as European Patient Smart Open Services (epSOS) and Schleswig-Holstein Health Initiative.

Browse more Healthcare IT related report at http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html

However, North America is the fastest growing region in the E-Prescribing market. Increased adoption of E-Prescribing system and improved healthcare infrastructure are major drivers for E-Prescribing market in North America. Moreover, several government initiatives are also promoting the usage of E-Prescribing system such as Health Information Technology for Economic and Clinical Health (HITECH) Act and National Council for Prescription Drugs Program.

In Asia, usage of E-Prescribing system is increasing due to medical infrastructure development and government initiative programs. Growing medical infrastructure has led to improvement in primary healthcare services, village clinics and urban healthcare centers through the adoption of healthcare IT technologies.

Download PDF at:E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

MTBE Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “MTBE Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure. Methyl tertiary butyl ether (MTBE) is a colorless, volatile, flammable liquid majorly used as fuel component. MTBE is manufactured by catalytic reaction of isobutylene with methanol. MTBE is used as an octane buster in engines. It is also used as oxygenate to increase oxygen in gasoline. MTBE offers good blending properties and reduces the content of formaldehyde and benzene in gasoline. Additionally, it replaces lead compounds enhancing the anti-knocking properties of the fuel. It is also used as a laboratory reagent to extract compounds. It is also used as solvent to dissolve gallstones. Furhermore, it is used as intermediate for methyl methacrylate.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/mtbe-market.html

MTBE is manufactured by reacting isobutene with methanol in a liquid phase reactor in presence of ion exchange resin. MTBE can further be processed to get isobutylene, which on further processing gives derivates such as methyl methacrylate (MMA), butyl rubber and polyisobutylene. Cost effectiveness and excellent blending octane value are the major advantages of methyl tertiary butyl ether. 

The market for methyl tertiary butyl ether (MTBE) was mainly driven by petrochemical applications. MTBE is majorly consumed as an octane buster and as anti-knocking agent in engines. MTBE is preferred over others due to its lower cost and effectiveness. MBTE finds application as a solvent and forms azeotropes with methanol and water. MBTE has various opportunities as a solvent in various chemicals. However, health and environmental issues related with MTBE can act as a major restraint for the market in upcoming years. Moreover, availability of substitutes also poses as a threat to the growth of the market. Additionally, biofuels mandate in European Union and the U.S. will be major constraint for the market.

In terms of demand, Asia Pacific was the leading region in MBTE market. Growing demand of MBTE from automotive engine market has been the major driver for the growth in the market. India, Japan and China are the major consumers of MTBE in Asia Pacific region. Asia Pacific was followed by North America where the demand for MBTE is anticipated to grow in upcoming years. U.S. and Canada are the leading countries and exhibit higher demand for MTBE in the North American region. Moreover, the demand for MTBE for fuel purpose is declining due to regulations in this region. In addition, there are some ground water concerns regarding MTBE in the U.S. However, the demand for MTBE is likely to grow from more lucrative markets such as Latin America and Europe. Europe is expected to be lucrative market for MTBE in near future. The Rest of the World market is expected to show greater potential for MTBE market in next few years. The Middle East market is likely to exhibit more demand for MTBE in upcoming years due to increased gasoline quality requirements in this region. 

Some of the key manufacturers in the MTBE market are Huntsman Corporation, LyondollBasell Industries, Oxeno Antewerpen, Panjin Hayen Industrial Group, Petroliam Nasional Berhad (Petronas), Saudi Basic Industries Corporation (SABIC), Zhenhai Refining and Chemical and Reliance Industries Ltd. among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of .

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth 
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 

More Reports On Chemical & Materials Market: - http://www.transparencymarketresearch.com/chemical-market-reports-2.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/

Ubiquitin Proteasome Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2013 – 2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “Ubiquitin Proteasome Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure. Proteasomes are the protein complexes present inside eukaryotes and a few prokaryotes. Proteolysis is the main function of these proteasomes, in which, unnecessary or damaged proteins are degraded by the breakage of peptide bonds catalyzed by enzymes called as proteases. This overall system of protein degradation is known as ubiquitin proteasome system.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/ubiquitin-proteasome-drugs.html

Ubiquitin proteasome system plays an important role in a variety of basic cellular processes and signaling pathways such as regulation of cell cycle, cell division and differentiation, DNA repair, transcriptional regulation, regulation of the immune responses and modulation of cell surface receptors. The regular degradation of proteins is crucial for maintenance of almost all biological processes including cell proliferation, cell metabolism and apoptosis.

Research in the field of ubiquitin proteasome is expanding exponentially. For instance, intensive research is going on in the field of applications of ubiquitin proteasome system in the treatment of cancer, as the pharmacological inhibition properties of proteasomes can be effective in cancer treatment. Potential sites of therapeutic interventions are also under research and the selective inhibition of disease specific components is also being studied for the purpose of developing treatments for diseases such as neurodegenerative disorders. This indicates a bright future market potential depending upon the time required for commercialization. Currently, there is only one approved ubiquitin proteasome system product available in the market named Velcade. In 2009, total sales of Velcade were estimated to be 1.4 billion and being the only approved drug, its sales are expected to achieve growth at a high compounded annual growth rate.

Although a lot of basic knowledge about the mechanism of ubiquitin proteasome systems is available, its real commercial potential has not yet been fully discovered. The market for ubiquitin proteasome can be divided into four segments on the basis of geography, namely North America, Europe, Asia-Pacific and Rest of the World.

Some of the companies involved in the research and development of ubiquitin proteasome systems are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Novelix Pharmaceuticals, Inc., GlaxoSmithKline Pharmaceuticals Ltd. and Onyx Pharmaceuticals, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth 
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 

More Reports On Pharmaceutical Market: - http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/

Blood Disease Treatment Drugs Market – Global Analysis and Industry Forecast, 2013-2019

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Sparkling Bottled Water Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure.

Blood comprises of red blood cells, white blood cells, plasma and platelets. Sometimes, people might be affected with different types of blood disorders and blood cancers due to aging, infections, exposure to certain chemicals, smoking, genetic disorders and other factors. 

Browse Full Report with TOC: http://www.transparencymarketresearch.com/blood-disease-treatment-drugs.html

Hence, the category of blood disorders is wide and numerous types of diseases fall under it. There are three main types of cancer that affect blood namely leukemia which affects the bone marrow and is caused by abnormal production of white blood cells. Myeloma is a type of blood cancer that affects plasma cells whereas lymphoma is a cancer that affects the lymphatic system. The diseases that affect white blood cells are mainly lymphoma and leukemia and  anemia, sickle cell anemia and polycythemia diseases are mainly affecting red blood cells. Diseases such as heparin, thrombocytopenia and essential thrombocytosis affect the platelets found in blood and hemophilia and sepsis affect blood plasma. 

Hematological cancers represent a significant problem globally. Every year more than 100,000 cases of blood cancers are diagnosed in United States and more than 50,000 people die from such cancer cases. Many specific therapies for the treatment of cancers have been developed that include biologics and small-molecule drug therapies. Leukemia accounts for the ninth most common occurring cancer in males across the globe. Leukemia market is segmented into four types that include acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. Thus, with the rise in number of cancer cases the market in future is projected to grow. 

Drugs such as Sprycel, Arranon, Clolar, Gleevec, Quizartinib, Marqibo, and Tasigna are the major drugs available for the treatment of leukemia. The blood diseases treatment drugs market is witnessing competition among the players with drugs in pipeline for early diagnosis and treatment of blood disorders. 

Some of the key players in the blood disease treatment drugs market include Novartis International AG, Celgene Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals, Ambit Bioscience and other major players.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports on Pharmaceutical Market:  http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. 

Contact Us 

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com 

Website: http://www.transparencymarketresearch.com/ 

Browse Market Research Report:- 

http://www.tmrblog.com/ 

http://marketingfirmblog.wordpress.com/

Global Treatments For Neurodegenerative Disorders Market

Neurodegenerative disorders cause progressive loss of function structure of the neurons in the human brain. The most commonly known neurodegenerative diseases are Alzheimer’s, Parkinson’s, Amyotrophic lateral sclerosis, and Huntington’s Syndrome. Most neurodegenerative disorders are caused because of genetic mutation in completely unrelated cells.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/neurodegenerative-disorders.html

Increase in the awareness regarding mental disorders and the rise in research and development regarding the treatment of such disorders are the major factors that are driving the growth of this market. However, despite large scale advancement in research in this field, there is a lack of complete curative treatment measures due to the manifold nature of the diseases. Moreover, many of the drugs presently available are for the treatment of symptoms of such diseases.

The market for neurodegenerative diseases can be categorized into major segments namely, progressive dementia, dementia with other neurological abnormalities and movement disorders. Out of these segments, the largest market share is occupied by progressive dementia followed by dementia with other neurological abnormalities. The major diseases segmented under neurodegenerative disorders are Huntington’s disease, Alzheimer’s disease, Pick’s disease, corticobasal ganglionic degeneration, Lewy body dementia, progressive supranuclear palsy, Hallervorden-Spatz disease, and multiple system atrophy.

Geographically, this market can be classified as North American, European, Asia Pacific, and the Rest of the World market. The major players in the neurodegenerative disorders market are Abbott Laboratories, Acorda Therapeutics, Inc., Baxter International, Inc., Boehringer Ingelheim Ltd., Cipla Ltd., Cellzome AG, Colucid Pharmaceuticals, Inc., Daiichi Sankyo Co. Ltd., Glenmark Generics Ltd., Neuro-Hitech, Inc., Roche Holding Ltd. and others.

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports On Pharmaceutical Market: -http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/

Factor And Growrh Of Continuous Glucose Monitoring(CGM) Market 2013 - 2019

The global continuous glucose monitorin(CGM) market was valued at USD 0.37 billion in 2012 and is expected to grow at a CAGR of 13.6% from 2013 to 2019, to reach an estimated value of USD 0.91 billion in 2019.

Browse Global Sterilization Equipment and Disinfectants Market Report with Full TOC athttp://www.transparencymarketresearch.com/continuous-glucose-monitoring.html

Continuous glucose monitoring systems (CGMS) are real time glucose monitoring devices that measure and display the glucose level of the interstitial fluid in the skin cells of the patient. These devices help patients manage diabetes (Type 1 and Type 2) in a more efficient manner. CGM devices typically comprise a sensor, transmitter and a receiver. The sensor is placed underneath the skin for monitoring glucose levels and is attached to the transmitter that relays the information to the monitor. Until recently, management of diabetes involved the use of conventional blood glucose meters that provided a single time snapshot of the patient's blood glucose level. However, demand for real time monitoring, minimally invasive and effective diabetes management solutions led to the advent of CGM devices. Rise in the incidence of diabetes globally coupled with increasing awareness of such devices that possess the ability to detect hyper and hypoglycemic events in real time will fuel the growth of this market during the forecast period.

CGM is a rapidly evolving market supported by increasing adoption of these systems by hospitals and individual practitioners who further encourage their patients to use these devices. However, CGM systems are not meant to be replaced by the traditional diabetes management devices. Hence, the technology still requires innovation in terms of accuracy and precision. Reimbursement issues, high cost of devices and low market penetration rates are some of the factors that are expected to hinder market growth in the near future. Medtronic's Guardian Real Time CGM System accounted for the largest share of the global marketin 2012, accounting for a share of over 40%. The product's first mover advantage in the market, proper positioning and marketing of the product, and ease of convenience and usability helped it achieve this leadership position. Dexcom's fourth generation product, namely, Dexcom G4 Platinum is anticipated to witness the highest market growth at a CAGR of 22.6% during the forecast period. G4 Platinum is the most recently launched device (2012) and is the most technologically advanced, offering more accuracy and reliability as compared to other commercially available devices. In addition, integration of this device with insulin pumps from various other manufacturers like Johnson & Johnson and Tandem Diabetes Care would also drive the growth of this market segment.

Geographically, North America captured majority share of the global continuous glucose monitoring market in 2012. Increase in type I diabetic population along with rise in geriatric population which will in turn spur the demand for regular monitoring of glucose levels will fuel the growth of this market. Major players of this market are domiciled in this region, which allows easy market penetration and will also contribute towards market growth. The European CGM market is in a rapidly evolving state and contributed the largest share of the total CGM market revenue in 2012. Asia-Pacific is expected to witness tremendous increase its market share and emerge as the fastest growing region, reporting a CAGR of 16.9% during the forecast period. Economic developments, presence of a large patient pool, rising patient awareness, increasing disposable income and changing lifestyle are some of the significant factors that are poised to increase the demand for CGM systems in this region.

Key players in this market include Medtronic, Inc., Dexcom, Inc. and Abbott Diabetes Care. Medtronic was the leading player of this market in 2012, accounting for a share of over 50%. Abbott saw a decline in its market share due to withdrawal of Free Style Navigator from the U.S. market in the fourth quarter of 2011. However, the expected launch of Free Style Navigator ll in 2014 in the U.S. market would help the company restore its market position. Other companies such as Johnson & Johnson, Bayer Healthcare and Tandem Diabetes Care are adopting the strategy of partnerships and collaboration to enter this dynamic market.

The global continuous glucose monitoring market is segmented as follows:

Continuous Glucose Monitoring Market, by Device/Brand

1. Guardian Real Time CGM System


2. Dexcom Seven Plus


3. Dexcom G4 Platinum


4. FreeStyle Navigator


5. MiniMed Paradigm Revel/Veo System


6. Others

BrowseSterilizationEquipmentandDisinfectants Market athttp://www.transparencymarketresearch.com/continuous-glucose-monitoring.html

Continuous Glucose Monitoring Market, by Geography

1. North America


2. Europe


3. Asia-Pacific


4. Rest of the World (RoW)

Browse all Medical Devices Market Research Reports @http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html